Intervention Review

Depot perphenazine decanoate and enanthate for schizophrenia

  1. Anthony David1,*,
  2. Seema N Quraishi1,
  3. John Rathbone2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 24 MAY 2005

DOI: 10.1002/14651858.CD001717.pub2

How to Cite

David A, Quraishi SN, Rathbone J. Depot perphenazine decanoate and enanthate for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001717. DOI: 10.1002/14651858.CD001717.pub2.

Author Information

  1. 1

    Institute of Psychiatry, London, UK

  2. 2

    Institute of Mental Health, Cochrane Schizophrenia Group, Nottingham, UK

*Anthony David, Institute of Psychiatry, De Crespigny Park, BOX PO68, London, SE5 8AF, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.